Biomed Central Ltd

SHERPA: Unknown

People

  1. Postow
    Postow
  2. Shoushtari
    Shoushtari
  3. Klebanoff
    Klebanoff
  4. Barker
    Barker
  5. Budhu
    Budhu
  6. Busam
    Busam
  7. Panageas
    Panageas
  8. Wong
    Wong
  9. Liu
    Liu
  10. Ariyan
    Ariyan

Groups

  1. Melanoma Disease Management Team (86)
  2. Department of Medicine (80)
  3. Solid Tumor Oncology Division (78)
  4. Melanoma and Immunotherapeutics Service (70)
  5. Hematologic Malignancies, Division of (34)
  6. GSK Faculty (33)
  7. Sloan Kettering Institute Postdocs (14)
  8. Hematology-Oncology Fellows (13)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (10)
  10. Department of Pathology and Laboratory Medicine (10)
Search Within
  1. "Melanoma Disease Management Team"
Formats
  1. Journal Article (38)
  2. Meeting Abstract (38)
  3. Editorial (4)
  4. Guidelines (3)
  5. Review (2)
  6. Miscellaneous (1)
Groups
  1. Melanoma Disease Management Team (86)
  2. Department of Medicine (80)
  3. Solid Tumor Oncology Division (78)
  4. Melanoma and Immunotherapeutics Service (70)
  5. Hematologic Malignancies, Division of (34)
  6. GSK Faculty (33)

More Groups

People
  1. Michael Postow (43)
  2. Jedd Wolchok (25)
  3. Alexander Shoushtari (21)
  4. Christopher Klebanoff (8)
  5. Margaret Callahan (8)
  6. Christopher Barker (7)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (5)
  4. 2022 (14)
  5. 2021 (10)
  6. 2020 (13)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (65)
  2. Journal of Translational Medicine (16)
  3. BMC Cancer (1)
  4. BMC Medical Genetics (1)
  5. Journal of Cardiovascular Magnetic Resonance (1)
  6. Journal of Negative Results in BioMedicine (1)

More Publications

Results (86)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allele-specific HLA LOH in solid tumors: Distinct patterns by tumor type and potential prognostic relevance
    Journal Article

    Sewastianik, T.; Roy, C.; Gormally, M.; Montesion, M.; Halvey, P.; Jindal, A.; Lam, H.; Schoenfeld, A.; Klebanoff, C. A.; Opiteck, G. J.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Gantry-based pencil beam scanning proton therapy for uveal melanoma: IMPT versus proton arc therapy
    Journal Article

    Qi, H.; Hu, L.; Huang, S.; Lee, Y. P.; Yu, F.; Chen, Q.; Yang, Y.; Kang, M.; Zhai, H.; Vermeulen, M.; more...
    Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Clinical benefit with tebentafusp in a patient with GNAQ mutant metastatic blue nevus-associated melanoma
    Journal Article

    Kudelka, M. R.; Richards, A. L.; Friedlander, P.; Wolchok, J. D.; Moy, A. P.; Shoushtari, A. N.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Corso, T.; Livingstone, P.; Tom, E.; Srivastava, A.; Postow, M.; Faleck, D.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
    Journal Article

    Sacco, J. J.; Carvajal, R. D.; Butler, M. O.; Shoushtari, A. N.; Hassel, J. C.; Ikeguchi, A.; Hernandez-Aya, L.; Nathan, P.; Hamid, O.; Piulats, J. M.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
    Guidelines

    Pavlick, A. C.; Ariyan, C. E.; Buchbinder, E. I.; Davar, D.; Gibney, G. T.; Hamid, O.; Hieken, T. J.; Izar, B.; Johnson, D. B.; Kulkarni, R. P.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Perspectives in immunotherapy: Meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
    Editorial

    Ascierto, P. A.; Avallone, A.; Bifulco, C.; Bracarda, S.; Brody, J. D.; Emens, L. A.; Ferris, R. L.; Formenti, S. C.; Hamid, O.; Johnson, D. B.; more...
    Journal of Translational Medicine (2023)

    Fulltext@MSK | Save
  • Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
    Journal Article

    Badran, Y. R.; Zou, F.; Durbin, S. M.; Dutra, B. E.; Abu-Sbeih, H.; Thomas, A. S.; Altan, M.; Thompson, J. A.; Qiao, W.; Leet, D. E.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Management of immune-related cutaneous adverse events with dupilumab
    Journal Article

    Kuo, A. M. S.; Gu, S.; Stoll, J.; Moy, A. P.; Dusza, S. W.; Gordon, A.; Haliasos, E. C.; Janjigian, Y.; Kraehenbuehl, L.; Quigley, E. A.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: A phase 1 study
    Journal Article

    Hamid, O.; Hassel, J. C.; Shoushtari, A. N.; Meier, F.; Bauer, T. M.; Salama, A. K. S.; Kirkwood, J. M.; Ascierto, P. A.; Lorigan, P. C.; Mauch, C.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save